NEWS & PRESS RELEASES
InnovHeart Featured in MedTech Strategist
We are pleased to announce that InnovHeart is featured in the MedTech Strategist October 2023 edition. The article "The Tantalizing Mitral Valve Device Market” by author Mary Stuart captures well InnovHeart’s commitment to enhancing the quality of life for millions of...
Presentation of Saturn at TVT – June 2023
View presentations on the novel SATURN TMVR technology with transseptal delivery, developed by Dr. Lauren S. Ranard in collaboration with Dr. Torsten Vahl, Dr. Paolo Denti, the staff from Skirball Center for Innovation, and InnovHeart R&D team, and presented at...
InnovHeart appoints David Wilson as Chief Executive Officer
Industry Leader to Guide Company and the Saturn TMVR Programin its Next Phase of Growth InnovHeart s.r.l. announced today the appointment of David James Wilson, an experienced healthcare and medical device executive as Chief Executive Officer of the company and...
InnovHeart raises $55 million in Series C financing to further develop the Trans-septal Saturn Transcatheter Mitral Valve Replacement System
InnovHeart and Grand Pharmaceutical Group Enter Into an Exclusive License Agreement to Develop and Commercialize the Saturn TMVR Device in Greater China Milan, January 27, 2022 - InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement...
“Learning and innovation go hand in hand.
The arrogance of success is to think that what you did yesterday
will be sufficient for tomorrow.”
William Pollard